Literature DB >> 12496155

Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates.

Klaus Panthel1, Wolfgang Jechlinger, Alexander Matis, Manfred Rohde, Michael Szostak, Werner Lubitz, Rainer Haas.   

Abstract

Bacterial ghosts are empty cell envelopes, which may be generated by the controlled expression of the PhiX174 lysis gene E in gram-negative bacteria to obtain vaccine candidates. We describe here the application of this technology to Helicobacter pylori. The lysis gene cassette was cloned into an Escherichia coli-Helicobacter pylori shuttle vector and introduced into an H. pylori recipient strain by bacterial conjugation. Temperature induction of the lysis gene cassette revealed a quantitative killing of the H. pylori culture without induction of lysis-resistant bacteria. Biochemical and transmission electron microscopic studies identified structurally intact H. pylori. Prophylactic oral vaccination experiments using these H. pylori ghosts in the BALB/c mouse model showed a significant reduction of the bacterial load in the ghost group, as measured by a quantitative bacterial reisolation procedure. Ten of 10 and 5 of 10 mice were protected, respectively, without the use of a mucosal adjuvant. Coadministration of ghosts with cholera toxin as mucosal adjuvant resulted in a complete protection of 10 of 10 and 8 of 8 mice against H. pylori challenge, with three animals showing a sterile immunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496155      PMCID: PMC143412          DOI: 10.1128/IAI.71.1.109-116.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein E.

Authors:  A Witte; G Wanner; U Bläsi; G Halfmann; M Szostak; W Lubitz
Journal:  J Bacteriol       Date:  1990-07       Impact factor: 3.490

2.  Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.

Authors:  L Nencioni; M Pizza; M Bugnoli; T De Magistris; A Di Tommaso; F Giovannoni; R Manetti; I Marsili; G Matteucci; D Nucci
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

Review 3.  The design of vaccines against Helicobacter pylori and their development.

Authors:  G Del Giudice; A Covacci; J L Telford; C Montecucco; R Rappuoli
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Oral immunization against Helicobacter pylori.

Authors:  S J Czinn; J G Nedrud
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

5.  A low-viscosity epoxy resin embedding medium for electron microscopy.

Authors:  A R Spurr
Journal:  J Ultrastruct Res       Date:  1969-01

6.  Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli.

Authors:  R C Valentine; B M Shapiro; E R Stadtman
Journal:  Biochemistry       Date:  1968-06       Impact factor: 3.162

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.

Authors:  D Bumann; W G Metzger; E Mansouri; O Palme; M Wendland; R Hurwitz; G Haas; T Aebischer; B U von Specht; T F Meyer
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

9.  Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity.

Authors:  A Labigne; V Cussac; P Courcoux
Journal:  J Bacteriol       Date:  1991-03       Impact factor: 3.490

10.  Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

Authors:  M Marchetti; M Rossi; V Giannelli; M M Giuliani; M Pizza; S Censini; A Covacci; P Massari; C Pagliaccia; R Manetti; J L Telford; G Douce; G Dougan; R Rappuoli; P Ghiara
Journal:  Vaccine       Date:  1998-01       Impact factor: 3.641

View more
  20 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  The oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori.

Authors:  Morris O Makobongo; Hanan Gancz; Beth M Carpenter; Dennis P McDaniel; D Scott Merrell
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  Generation of Vibrio anguillarum ghost by coexpression of PhiX 174 lysis E gene and staphylococcal nuclease A gene.

Authors:  Se Ryun Kwon; Yue Jai Kang; Dong Jin Lee; Eun Hye Lee; Yoon Kwon Nam; Sung Koo Kim; Ki Hong Kim
Journal:  Mol Biotechnol       Date:  2009-02-04       Impact factor: 2.695

4.  Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/λ PR/gene E expression system.

Authors:  Chetan V Jawale; Atul A Chaudhari; Byung Woo Jeon; Rahul M Nandre; John Hwa Lee
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

5.  Lack of stage-specific proteins in coccoid Helicobacter pylori cells.

Authors:  Dirk Bumann; Hajar Habibi; Biao Kan; Monika Schmid; Christian Goosmann; Volker Brinkmann; Thomas F Meyer; Peter R Jungblut
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

Review 6.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

7.  Two-component systems of Helicobacter pylori contribute to virulence in a mouse infection model.

Authors:  Klaus Panthel; Patricia Dietz; Rainer Haas; Dagmar Beier
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Enhancement of bacteriolysis of shuffled phage PhiX174 gene E.

Authors:  Shen-ye Yu; Wei Peng; Wei Si; Lu Yin; Si-guo Liu; Hui-fang Liu; Hai-ling Zhao; Chun-lai Wang; Yue-hong Chang; Yue-zhi Lin
Journal:  Virol J       Date:  2011-05-06       Impact factor: 4.099

9.  Leptin, CD4(+) T(reg) and the prospects for vaccination against H. pylori infection.

Authors:  Anna K Walduck; Dorit Becher
Journal:  Front Immunol       Date:  2012-10-15       Impact factor: 7.561

10.  Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteria.

Authors:  Masoud Sabouri Ghannad; Avid Mohammadi
Journal:  Iran J Basic Med Sci       Date:  2012-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.